Docoh
Loading...

SOPH SOPHiA Genetics

Filed: 10 Nov 21, 7:13am

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the month of November 2021.

 

 

 

Commission File Number: 001-40627

 

SOPHiA GENETICS SA

(Exact name of registrant as specified in its charter)

 

Rue du Centre 172

CH-1025 Saint-Sulpice

Switzerland

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

 Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 SOPHiA GENETICS SA
Date: November 10, 2021 
  
 By:/s/ Daan van Well
 Name:Daan van Well
 Title:Chief Legal Officer

 

EXHIBIT INDEX

 

Exhibit No.Description
99.1Unaudited interim condensed consolidated financial statements as of and for the three and nine months ended September 30, 2021
99.2Management’s discussion and analysis of financial condition and results of operations
99.3Press Release dated November 10, 2021